Literature DB >> 28546132

Identification of direct target genes of miR-7, miR-9, miR-96, and miR-182 in the human breast cancer cell lines MCF-7 and MDA-MB-231.

Hamidreza Moazzeni1, Ali Najafi2, Marzieh Khani3.   

Abstract

Some microRNAs have carcinogenic or tumor suppressive effects in breast cancer, which is the most common cancer in women worldwide. MiR-7 and miR-9 are tumor suppressor microRNAs, which induce apoptosis and inhibit proliferation in breast cancer cells. Moreover, miR-96 and miR-182 are onco-microRNAs that increase proliferation, migration, and tumorigenesis in breast cancer cells. This study aimed to identify the direct target genes of these four microRNAs in the human breast cancer cell lines MCF-7 and MDA-MB-231. Initially, bioinformatics tools were used to identify the target genes that have binding sites for miR-7, MiR-9, MiR-96, and miR-182 and are also associated with breast cancer. Subsequently, the findings of the bioinformatics analysis relating to the effects of these four microRNAs on the 3'-UTR activity of the potential target genes were confirmed using the dual luciferase assay in MCF-7 and MDA-MB-231 cells co-transfected with the vectors containing 3'-UTR segments of the target genes downstream of a luciferase coding gene and each of the microRNAs. Finally, the effects of microRNAs on the endogenous expression of potential target genes were assessed by the overexpression of each of the four microRNAs in MCF-7 and MDA-MB-231 cells. Respectively, three, three, three, and seven genes were found to have binding sites for miR-7, miR-9, miR-96, and miR-182 and were associated with breast cancer. The results of empirical studies including dual luciferase assays and real-time PCR confirmed that miR-7 regulates the expression of BRCA1 and LASP1; MiR-9 regulates the expression of AR; miR-96 regulates the expression of ABCA1; and miR-182 regulates the expression of NBN, TOX3, and LASP1. Taken together, our results suggest that the tumor suppressive effects of miR-7 may be mediated partly by regulating the expression of BRCA1 as a tumor suppressor gene in breast cancer. In addition, this microRNA and miR-182 may have effects on the nodal-positivity and tumor size of breast carcinoma through the regulation of LASP1. The tumor suppressive functions of miR-9 may be mediated partly by suppressing the expression of AR-an oncogene in breast cancer. Moreover, miR-96 may play an oncogenic role in breast cancer by suppressing the apoptosis through the regulation of ABCA1.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; MicroRNA; Oncogene; Tumor suppressor

Mesh:

Substances:

Year:  2017        PMID: 28546132     DOI: 10.1016/j.mcp.2017.05.005

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  13 in total

1.  Significant association of TOX3/LOC643714 locus-rs3803662 and breast cancer risk in a cohort of Iranian population.

Authors:  Amir Tajbakhsh; Fahimeh Afzal Javan; Mahdi Rivandi; Atefeh Moezzi; Soheila Abedini; Mahla Asghari; Zahra Farjami; Hosein Soltanian; Fatemeh Homaei Shandiz; Mohammad Mahdi Kooshyar; Alireza Pasdar
Journal:  Mol Biol Rep       Date:  2018-12-04       Impact factor: 2.316

2.  Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms.

Authors:  Rakesh Mandal; Heather Hardin; Rebecca Baus; William Rehrauer; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

3.  miR-182 modulates cell proliferation and invasion in prostate cancer via targeting ST6GALNAC5.

Authors:  Liang Bai; Li Luo; Weicheng Gao; Chenfeng Bu; Jianfeng Huang
Journal:  Braz J Med Biol Res       Date:  2021-05-24       Impact factor: 2.590

Review 4.  Sensational MicroRNAs: Neurosensory Roles of the MicroRNA-183 Family.

Authors:  Samantha A Banks; Marsha L Pierce; Garrett A Soukup
Journal:  Mol Neurobiol       Date:  2019-07-29       Impact factor: 5.682

5.  Elevated circulating miR-182 acts as a diagnostic biomarker for early colorectal cancer.

Authors:  Xiangxiang Liu; Tao Xu; Xiuxiu Hu; XiaoXiang Chen; Kaixuan Zeng; Li Sun; Shukui Wang
Journal:  Cancer Manag Res       Date:  2018-04-24       Impact factor: 3.989

6.  Specific breast cancer prognosis-subtype distinctions based on DNA methylation patterns.

Authors:  Shumei Zhang; Yihan Wang; Yue Gu; Jiang Zhu; Ce Ci; Zhongfu Guo; Chuangeng Chen; Yanjun Wei; Wenhua Lv; Hongbo Liu; Dongwei Zhang; Yan Zhang
Journal:  Mol Oncol       Date:  2018-05-21       Impact factor: 6.603

7.  Genetic Variants in pre-miR-146a, pre-miR-499, pre-miR-125a, pre-miR-605, and pri-miR-182 Are Associated with Breast Cancer Susceptibility in a South American Population.

Authors:  Sebastián Morales; Tomas De Mayo; Felipe Andrés Gulppi; Patricio Gonzalez-Hormazabal; Valentina Carrasco; José Miguel Reyes; Fernando Gómez; Enrique Waugh; Lilian Jara
Journal:  Genes (Basel)       Date:  2018-08-22       Impact factor: 4.096

8.  MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9.

Authors:  Yuan Lv; Dong Ye; Shijie Qiu; Jian Zhang; Zhisen Shen; Yi Shen; Hongxia Deng
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.976

9.  Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.

Authors:  Federica Baldassari; Carlotta Zerbinati; Marco Galasso; Fabio Corrà; Linda Minotti; Chiara Agnoletto; Maurizio Previati; Carlo M Croce; Stefano Volinia
Journal:  Front Genet       Date:  2018-05-18       Impact factor: 4.772

Review 10.  New Frontiers for the Cytoskeletal Protein LASP1.

Authors:  Elke Butt; Dayanidhi Raman
Journal:  Front Oncol       Date:  2018-09-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.